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ABSTRACT 
OBJECTIVE: To translate, cross-culturally adapt and validate the Diabetes Empowerment 
Scale – Short Form for assessment of psychosocial self-efficacy in diabetes care within the 
Brazilian cultural context.
METHODS: Assessment of the instrument’s conceptual equivalence, as well as its translation 
and cross-cultural adaptation were performed following international standards. The Expert 
Committee’s assessment of the translated version was conducted through a web questionnaire 
developed and applied via the web tool e-Surv. The cross-culturally adapted version was used 
for the pre-test, which was carried out via phone call in a group of eleven health care service 
users diagnosed with type 2 diabetes mellitus. The pre-test results were examined by a group of 
experts, composed by health care consultants, applied linguists and statisticians, aiming at an 
adequate version of the instrument, which was subsequently used for test and retest in a sample 
of 100 users diagnosed with type 2 diabetes mellitus via phone call, their answers being recorded 
by the web tool e-Surv. Internal consistency and reproducibility of analysis were carried out 
within the statistical programming environment R.
RESULTS: Face and content validity were attained and the Brazilian Portuguese version, entitled 
Escala de Autoeficácia em Diabetes – Versão Curta, was established. The scale had acceptable 
internal consistency with Cronbach’s alpha of 0.634 (95%CI 0.494– 0.737), while the correlation 
of the total score in the two periods was considered moderate (0.47). The intraclass correlation 
coefficient was 0.50.
CONCLUSIONS: The translated and cross-culturally adapted version of the instrument to 
spoken Brazilian Portuguese was considered valid and reliable to be used for assessment within 
the Brazilian population diagnosed with type 2 diabetes mellitus. The use of a web tool (e-Surv) 
for recording the Expert Committee responses as well as the responses in the validation tests 
proved to be a reliable, safe and innovative method.
DESCRIPTORS: Diabetes Mellitus. Cost of Illness. Surveys and Questionnaires. Translations. 
Reproducibility of Results. Validation Studies. 
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INTRODUCTION
Diabetes mellitus is one of the most common chronic conditions in the world. Brazil has the 
highest prevalence in South America with about 11.9 million people. Educational practices 
in relation to diabetes are intended to promote health service users taking responsibility 
for their own care. This can reduce risk of complications and increase their quality of life1. 
These educational practices cover behavioral, psychosocial and clinical aspects of the heath 
service users with diabetes2,a.
Experts from the University of Michigan, USA, prepared, adapted and validated the Diabetes 
Empowerment Scale (DES), originally made up of 37 questions, into a short version named 
Diabetes Empowerment Scale – Short Form (DES-SF). The abridged instrument is made 
up of eight questions addressing the evaluation of psychosocial empowerment and covers 
the following domains: need for behavior change, development of a care plan, overcoming 
barriers, soliciting support, caring for oneself, managing emotions, personal motivations, 
and making decisions about diabetes care1,3,4. 
The DES-SF stands out among the instruments that evaluate empowerment in diabetes10,17, 
being effective, brief, practical and quickly administered. It can be implemented through 
telephone call to a large number of users, before and after an educational intervention2,3.
A group of researchers at the School of Nursing, together with the Laboratory for 
Experimentation in Translation of the Faculdade de Letras and the Department of Statistics 
at Universidade Federal de Minas Gerais (UFMG), has been carrying out studies on the 
translation, adaptation and validation of health instruments within the scope of the project 
Empodera – Inovação metodológica nas práticas educativas orientadas à autonomia no cuidado 
em saúde (Empodera – Methodological innovation in educational practices oriented to 
autonomy in health care). The group detected the need to use DES-SF in educational practices 
aimed at assessing users’ psychosocial aspects and to provide health professionals with an 
instrument that evaluates empowerment in diabetesb.
This paper reports a study carried out in order to translate, cross-culturally adapt, and 
validate the DES-SF for application in the Brazilian cultural context.
METHODS
Authorization was first requested and obtained from the main author1,8 of the DES-SF so as to 
translate, cross-culturally adapt and validate the instrument for Brazilian health service users. 
A first analysis of the original instrument explored concepts related to diabetes to 
verify if the instrument dimensions were relevant to the Brazilian cultural context. 
A comprehensive bibliographic review as well as interdisciplinary meetings of health and 
applied linguistics professionals and members of the Center for Management, Education 
and Health Assessment (NUGEAS) of the Nursing School of the UFMG were carried out 
for discussion and instrument evaluation.
Once the feasibility and pertinence of using DES-SF in Brazil was ascertained, two 
Brazilian translators, with a first degree in Translation and Linguistic Studies, were 
requested to produce a forward translation. The two Brazilian Portuguese versions 
thereby obtained were compared and a synthesis version generated, which was 
submitted to back-translation. A professor of Translation and Linguistic Studies, 
specialized in translation and cross-cultural adaptation of medical instruments, 
analyzed the originals and back-translations and generated a final version carefully 
checked to ensure semantic equivalence.
A consolidated final version was obtained, which was submitted for examination to an 
interdisciplinary committee of experts, with 19 applied linguistics professionals and 
a International Diabetes 
Federation. Diabetes 
atlas. Brussels; 2014 
[cited 2015 Mar 19]. Available 
from: http://www.idf.org/
diabetesatlas
b Torres HC, Reis IA, Pagano 
AS. Empoderamento do 
pesquisador nas ciências da 
saúde. Belo Horizonte (MG): 
FALE/UFMG; 2015.
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19 health professionals. A questionnaire to assess the translated version was used through 
the web tool e-Surv5. Each item in English was followed by its translation and a text box 
was provided for the experts to paraphrase in their own words what the question meant. 
After that, experts were asked: a) “Do you think the Portuguese text is in line with the 
English text?” and b) “Do you think the proposed translation is clear and easy for the 
respondent to understand it?” The response options were: “Yes”, “no” and “partially”. 
If “no” and “partially” were the chosen answers, the respondent was requested to point out 
inadequacies and provide suggestions to improve the translated item. Face and content 
validity of the instrument were analyzed.
For the pre-test, the version obtained after the committee’s assessment was used and the 
questionnaire was applied via telephone call to a group of 11 users with type 2 diabetes 
mellitus. Users were male and female, ranging from 30 to 75 year old and able to listen 
and verbally respond to the questions in the instrument. Patients with diabetes chronic 
complications such as chronic dialysis renal insufficiency; blindness; limb amputation and 
severe psychiatric disorders were not excluded from the sample. 
A questionnaire on the web tool e-Surv was used to record users’ comprehension of 
the translated questionnaire items, with indication of the following options to rate 
comprehension: 1) The user understood the statement easily; 2) The user had difficulty in 
understanding the statement; 3) The user asked for the statement to be repeated more than 
once; and 4) The user was unresponsive to the statement. After three applications of the 
translated questionnaire with different groups of users, results were discussed by a group of 
specialists, made up of applied linguistics, health and statistics professionals, whose research 
focused on cultural adaptation of instruments and diabetes. Adjustments in the wording of 
some of the items were made in order to facilitate users’ comprehension. After four meetings, 
the final version of the instrument was achieved (Table 1).
Table 1. Original version and final version of the instrument, translated and cross-culturally adapted. Brazil, 2015.
Original version Final version
Diabetes Empowerment Scale-Short Form (DES-SF) Escala de Autoeficácia em Diabetes Versão Curta (EAD-VC) 
The 8 items below constitute the DES-SF. The scale is scored by 
averaging the scores of all completed items (Strongly Disagree =1, 
Strongly Agree = 5)
Eu (profissional de saúde) vou falar algumas questões sobre como o(a) 
senhor(a) está cuidando do diabetes. E ai o senhor/a senhora me fala se: 
Check the box that gives the best answer for you O senhor / A senhora:
Strongly Disagree Não está de acordo de jeito nenhum
Somewhat Disagree Não está de acordo
Neutral Não tem opinião
Somewhat Agree Está de acordo
Strongly Agree Está muito de acordo
In general, I believe that I: Em geral, eu acredito que:
1. ...know what part(s) of taking care of my diabetes that I am dissatisfied with.
1. O(A) senhor(a) sabe que coisas tem de fazer para cuidar da sua saúde, 
mas não gosta de fazer.
2. …am able to turn my diabetes goals into a workable plan.
2. O(A) senhor(a) pode programar o seu dia a dia com coisas que vão 
ajudar o(a) senhor(a) a cuidar da sua saúde.
3. ...can try out different ways of overcoming barriers to my diabetes goals.
3. O(A) senhor(a) pode tentar coisas diferentes para afastar as dificuldades 
e fazer o que disse que ia fazer para controlar o diabetes.
4. ...can find ways to feel better about having diabetes.
4. O(A) senhor(a) acredita que tem como achar coisas diferentes para fazer 
e sentir bem.
5. ...know the positive ways I cope with diabetes-related stress.
5. O(A) senhor(a) pode viver bem e dar um jeito de ir levando esse estresse 
todo do diabetes.
6. ...can ask for support for having and caring for my diabetes when I need 
it.
6. Quando precisar tem como o(a) senhor(a) pedir ajuda para cuidar do 
diabetes.
7. ...know what helps me stay motivated to care for my diabetes.
7. O(A) senhor(a) sabe o que faz o(a) senhor(a) ficar mais motivado para 
cuidar do diabetes.
8. ...know enough about myself as a person to make diabetes care choices 
that are right for me.
8. O(A) senhor(a) sabe bem como é que o(a) senhor(a) é, não sabe? Então, 
dá para o(a) senhor(a) escolher direitinho o que vai dar certo para o(a) 
senhor(a) cuidar da sua saúde.
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This version was applied to 100 users with type 2 diabetes mellitus via telephone call. Simple 
random sampling process was used and the G-Power software to calculate sample size. A 5% 
significance level, a 80.0% test power, equal standard deviations in the test and retest scores, 
and a 0.30 correlation coefficient (minimum value detected in the consistency assessment) 
were considered; the minimum sample size was 82 users. Considering the friction rate of no 
more than 20.0%, 100 users made up the initial sample9.
The instrument was applied twice (test and retest) with a 15-day interval as recommended 
in the literature for this validation step8,23. The same interviewer conducted the first and 
second interviews at the same scheduled times.
The interviewer recorded the answers in a questionnaire using the tool web e-Survc, with 
a questionnaire made up by the following sections: 1) Instructions for the interviewer; 
2) Sociodemographic and clinical data of the user; 3) translated and cross-culturally adapted 
instrument; and 4) Interviewer’s remarks. 
In section 1, the interviewer welcomed the user, explained the study, especially its aims, 
obtained their consent to participate, provided answers to user inquiries, and requested 
permission to record the call. In section 2, the interviewer collected sociodemographic data 
and clinical information, such as when diabetes had been diagnosed, type of treatment and 
health problems. In section 3, the interviewer read each question from the adapted version 
of the instrument. The Likert scale used was “I totally agree” – 5 points; “I agree” – 4 points; 
“I have no opinion” – 3 points; “I disagree” – 2 points; and “I totally disagree” – 1 point. The final 
score was estimated by the mean of the scores in the eight questions; high score being from 
3.8 to 5.0, moderate from 2.4 to 3.7 and low from 1 to 2.31.
Sample data was analyzed according to sociodemographic and clinical variables. 
The Cronbach’s alpha coefficient (internal consistency) and the Spearman’s correlation 
coefficient (correlation between the responses to the instrument items at test and retest 
times) were used as a measure of agreement between two measurements for the reliability 
assessment. The latter was chosen due to its lower sensitivity to discrepant values, compared 
to its parametric version6. The intraclass correlation coefficient (ICC) was also used as a 
measure of agreement between the total score in two instrument applications, while the 
Wilcoxon test verified statistical difference between the median score of the first and second 
applications of the instrument. The significance level for statistical inference was 5.0%15.
The data were stored with code identifier in a data spreadsheet and imported for analysis 
within the statistical programming environment Rd. 
The Ethics Committee on Research Involving Human of the Health Secretariat of Belo Horizonte 
and the Ethics Committee on Human Research of the UFMG (Opinion 1,018,006/2015) 
granted approval to this study. Before recording the telephone calls, the users’ consent to 
participate in the study and to answer the questionnaire questions was recorded.
RESULTS
The analysis of conceptual and item equivalence between the original and the translated 
and the cross-culturally adapted versions contributed to the consolidation of a 
consensual version of the scale in Brazilian Portuguese, called Escala de Autoeficácia em 
Diabetes – Versão Curta (EAD-VC). 
The expert committee assessment found question 6 to have a high frequency of answers 
indicating the need to adapt the proposed translation from English into Portuguese, with 
31.6% in the group of linguistic studies specialists and 57.9% in the group of healthcare 
professionals. In the other questions, “partially” and “no” answers in the group of healthcare 
professionals were more frequent. Respondents suggestions were extensively discussed until 
obtaining the final version. 
c e-Surv. Reino Unido; 
2001 [cited 2015 Jan 6]. 
Available from: https://eSurv.
org?s=LIEJOO_dcfefe5e
d R Development Core Team. 
R Foundation for Statistical 
Computing. Viena; 2014 
[cited 2015 Jan 20]. Available 
from: http://www.R-project.org/
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The final version was used for the pre-test in a sample of 11 health service users. 60.0% 
of the users found it difficult to understand three questions (2, 6 and 7), the interviewer 
having been requested to repeat the question and explain it. Therefore, these questions 
were reworded into versions with more easily understood items, such as using “motivated” 
rather than “animated”, “care” rather than “treat”, “program” instead of “plan.” The first person 
pronoun (“I”) was changed into the third person and a politeness marker used “sir/madam”, 
so as to facilitate the interviewer’s spoken interaction with the user and the application via 
telephone call.
To analyze the instrument reliability, a 100-user sample of Basic Health Unit users with diabetes 
mellitus type 2 was used. Among the interviewees, 38.0% had incomplete basic education 
and 66.0% were inactive (retired or homemaker) (Table 2). The mean age was 61.3 years 
(SD = 8.7 years), while the mean length of diabetes condition was 10 years (SD = 7.6 years). 
The mean self-efficacy in the test was 4.4 (SD = 0.5) and, in retest, 4.4 (SD = 0.4) (Table 3). 
The Cronbach’s alpha assessed the internal consistency considering the first application 
data, before the users had any contact with the instrument. The Escala de Autoeficácia em 
Diabetes – Versão Curta (EAD-VC) presented a Cronbach’s alpha = 0.634 (95%CI 0.494–0.737) 
and its internal consistency was acceptable. 
Cronbach’s alpha took one question at a time (Table 4), to evaluate the influence of each 
item on the internal consistency of the instrument. Comparing only the values of the alpha 
point estimates, just the removal of item 1 increased the value of the alpha point estimate. 
Item 1 had the highest rates of discordance in the test and in the retest, with more divergent 
responses than the answers to the other items. With the removal of item 1, the total score 
of the scale became more homogeneous, increasing the alpha index.
The instrument reliability used the correlation between the responses to each item of the 
test and the retest with the Spearman’s correlation coefficient (Table 4). Despite the low 
value of this coefficient in some questions (3, 5 and 8), the total score concordance was 
considered moderate (0.47). For questions 3 and 8, responses in the “agree” and “strongly 
agree” categories in the test (question 3) or in the retest (question 8) were higher (Table 3). 
Furthermore, examining the cross-over of answers to questions 3 and 8 in the test and 
retest (not shown in the text) showed that most users who said they were “in agreement” 
Table 2. Characterization of the sample studied for validation of the Diabetes Empowerment Scale – Short 
Form (DES-SF). Brazil, 2015.
Characteristic Frequency %
Sex Male 39 39.0
Female 61 61.0
Schooling Illiterate 8 8.0
Incomplete elementary school 38 38.0
Complete elementary school 34 34.0
Incomplete high school 2 2.0
Complete high school 14 14.0
Higher education 4 4.0
Occupation Active 34 34.0
Inactive 66 66.0
Marital status With no partner 36 36.0
With a partner 64 64.0
Treatment No use of Insulin and Oral 
agents
1 1.0
Insulin 16 16.0
Oral agents 17 17.0
Insulin and Oral agents 36 36.0
Total 100 100
6Validation of DES-SF Chaves FF et al.
https://doi.org/10.1590/S1518-8787.2017051006336
or “agree a lot” at the first moment also chose one of these two responses in the second 
moment (97.0% and 100%, respectively). However, this high concentration of answers in 
two categories at one of the moments caused many draws at the stations used to calculate 
the Spearman’s coefficient, leading to very low values for the coefficient in these questions, 
since it is sensitive to draws. 
The analysis of the intraclass correlation coefficient supported the test-retest reliability of 
the instrument after two weeks, with moderate agreement (ICC = 0.50; 95%CI 0.495–0.504). 
The median score at the time of retest was higher than the median test score (difference between 
the medians equal to 1 point; Wilcoxon test, p = 0.013). However, by reducing the responses to 
three options (“I disagree or agree a lot”, “I have no opinion” and “I agree or strongly agree”), 
the difference between the median scores was statistically insignificant (difference between 
the sample medians equal to zero; Wilcoxon test, p = 0.757). 
Both applications showed a difference in response time to the instrument in the test-retest. 
All users took five to ten minutes to complete the test and less than five minutes to complete 
the retest. Sociodemographic and clinical data were collected in the second section of the 
e-Surv questionnaire.
Table 4. Correlation between test and retest responses (item by item and total score) and Cronbach’s 
alpha coefficient (α) for Diabetes Empowerment Scale – Short Form. Brazil, 2015.
Questions
Spearman’s Correlation 
Coefficient – test and retest
Cronbach’s alpha if the item is 
removed
95%CI
1 0.24 0.709 0.561–0.803
2 0.28 0.602 0.449–0.709
3 0.10 0.592 0.424–0.710
4 0.51 0.585 0.419–0.692
5 0.18 0.595 0.453–0.700
6 0.51 0.542 0.377–0.662
7 0.40 0.577 0.400–0.687
8 0.06 0.606 0.457–0.711
Total score 0.47 0.634 0.494–0.737
Table 3. Absolute frequency distribution of scores for each instrument question at test and retest times. 
Brazil, 2015.
Variable Assessment
Score
1 2 3 4 5
Question 1 Test 14 13 2 47 24
Retest 21 3 0 38 38
Question 2 Test 1 6 0 30 63
Retest 2 4 2 20 72
Question 3 Test 0 0 0 51 45
Retest 2 1 0 27 70
Question 4 Test 1 8 0 35 56
Retest 1 2 0 22 75
Question 5 Test 3 1 0 45 51
Retest 6 2 0 24 68
Question 6 Test 8 3 1 19 69
Retest 4 5 0 18 73
Question 7 Test 4 2 3 27 64
Retest 6 1 2 9 82
Question 8 Test 1 1 0 25 73
Retest 0 0 0 16 84
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DISCUSSION
The evaluation of conceptual and item equivalence led to the translated and cross-culturally 
adapted version of the instrument that is viable and practical for educational actions geared 
towards diabetes care in Brazil. Face and content were found adequate. The expert committee 
and the test and pre-test users found the understanding of the items satisfactory. The test 
and pre-test users had various levels of schooling, a criterion adopted to determine which 
language was appropriate for all levels, following the recommendations in the literature12,13,19. 
The instrument was found to be suitable as spoken text and to facilitate interaction and user 
comprehension as well as adequate to the Brazilian cultural context7,18. 
Internal consistency analysis provided Cronbach’s alpha value of 0.634 (95%CI 0.494–0.737). 
This result is acceptable in the literature23. The studies13,14,16,20, which validated the original 
version of the instrument with 37 questions, showed Cronbach’s alpha values above 0.70. 
Studies describing the validation of translated and adapted DES-SF versions are not available 
in the literature in order to compare with our results. Moreover, Tavakol and Dennick23 
(2011) state that the Cronbach’s alpha value is affected by the size of the instrument, a short 
instrument tending to have a low alpha value.
The retest median score can be equal to the test median score, indicating no statistically 
significant changes in the users’ empowerment between the test and the retest. 
There are different instruments in the literature that assess empowerment in diabetes10,17,22. 
However, the Escala de Autoeficácia em Diabetes – Versão Curta (EAD-VC) stands out for 
its ease and feasibility of application. Most significantly, its application via telephone call 
is viable; the instrument can be also used as a process and result indicator of educational 
practices in diabetes, which allows for longitudinal care24,25. 
The validation process of this study provided three main findings. The first, made during the 
application of the instrument, concerns the need to problematize the relevance and adequacy of a 
Likert scale with five options. This is because users tend to agree or disagree with a given question 
without, however, being able to quantify the intensity of such agreement or disagreement. This 
confirms observations in previous studies and it suggests the need to adapt the scale to three 
options10-12,21. However, the number of categories of the scale in this study was kept to five so 
that the results of the DES-SF application were comparable to studies in other countries2,3.
We observed the second finding in the retest application, in which some users answered 
differently some of the questions. A study18 that focused on the respondents’ behavior from 
communities of Latin American descendants in the United States pointed to randomness 
in the participants’ responses with low schooling and advanced age (> 60 years). Similar 
characteristics of the users interviewed in this study may explain the moderate ICC outcomes 
(0.50) and Spearman (0.47).
The third finding concerns the use of a questionnaire implemented through a web tool 
such as e-Surv, which proved to be a reliable, safe and innovative methodology. It allowed 
for consolidating responses by healthcare professionals, applied linguistics specialists and 
statistics specialists during the cross-cultural adaptation of the instrument, during the 
consultation to the expert committee; it also offered the possibility of experts participation 
without the need to relocate or leave their offices. This also favored the feeling of anonymity 
and allowed the participants to express certain opinions that they would not dare to if the 
whole procedure had been carried out in face-to-face interaction5. The tool also facilitated 
data collection in the validation tests, since the spreadsheet with the interview information 
is generated automatically, only requiring few adjustments to import and analysis within 
the statistical programming environment R17.
This study contributed to provide a comprehensible and feasible instrument to be applied via 
telephone call to a large number of users for the evaluation of psychosocial empowerment. 
This is meant to improve diabetes care in Brazil16.
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The need to carry out further studies to obtain further evidence of EAD-VC validity and reliability, 
using other representative samples, including healthcare users from different regions in Brazil, 
is a limitation of this study. This limitation will be solved in a continuous process of instrument 
evaluation; this process must be sensitive to the evolution of the instrument construct. 
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